Bruker (BRKR)
(Delayed Data from NSDQ)
$64.54 USD
+0.81 (1.27%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $64.54 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$64.54 USD
+0.81 (1.27%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $64.54 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth A Momentum C VGM
Zacks News
Bruker Rides on PCI Sales, Coronavirus-Led Supply Issues Hurt
by Zacks Equity Research
Bruker (BRKR) expects a rise in sales within life science, biopharma and basic medical research, as well as in infectious disease diagnostics due to the pandemic.
New Strong Sell Stocks for May 28th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Bruker (BRKR) Q1 Earnings Miss Estimates, Guidance Suspended
by Zacks Equity Research
Bruker's (BRKR) first-quarter 2020 results reflect dismal performance by all segments and geographies due to coronavirus-led business disruptions.
Bruker (BRKR) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Bruker (BRKR) delivered earnings and revenue surprises of -36.36% and -1.25%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Bruker (BRKR) Reports Next Week: What You Should Expect
by Zacks Equity Research
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Bruker (BRKR) Down 8.1% Since Last Earnings Report?
by Zacks Equity Research
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for April 6th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Bruker (BRKR) Q4 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Bruker's (BRKR) fourth-quarter 2019 results reflect strong performances by the majority of its segments and geographies.
Bruker Inks Deal to Distribute Coronavirus Detection Test
by Zacks Equity Research
The agreement would make Bruker (BRKR) a key player in coronavirus diagnosis.
Bruker (BRKR) Stock Rises on Strong Preliminary Q4 Show
by Zacks Equity Research
Bruker's (BRKR) revenue growth is expected to beat expectations for the fourth quarter and 2019.
What's in the Cards for MercadoLibre's (MELI) Q4 Earnings?
by Zacks Equity Research
MercadoLibre's (MELI) fourth-quarter results are likely to have benefited from its fintech and logistics offerings. However, rising expenses remained a concern.
Akamai (AKAM) Gears Up for Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Akamai's (AKAM) fourth-quarter results are expected to reflect solid adoption of Kona Site Defender and Prolexic Solutions.
Bruker (BRKR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Bruker (BRKR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FUJIFILM (FUJIY) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
FUJIFILM's (FUJIY) third-quarter fiscal 2020 results are expected to reflect robust performance of the Healthcare business.
Take Two (TTWO) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Take Two Interactive's (TTWO) Q3 results are expected to reflect benefits from portfolio strength and solid increase in recurrent consumer spending supported by new and existing franchise games.
Twitter (TWTR) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Twitter's (TWTR) fourth-quarter 2019 results are expected to reflect initiatives, including security measures to boost user engagement, despite intensifying competition for ad dollars.
Pinterest (PINS) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Pinterest's (PINS) fourth-quarter 2019 results are likely to benefit from user base expansion and strong ARPU growth.
What's in Store for American Superconductor (AMSC) Q3 Earnings?
by Zacks Equity Research
American Superconductor's (AMSC) fiscal third-quarter results are likely to have benefited from strengthening D-VAR shipments, VVO products and increasing REG revenues.
VeriSign (VRSN) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
VeriSign's (VRSN) fourth-quarter 2019 earnings are expected to have benefited from consistent increase in the number of .com and .net domain name registrations.
Factors Setting the Tone for Zendesk's (ZEN) Q4 Earnings
by Zacks Equity Research
Zendesk's (ZEN) fourth-quarter 2019 results are likely to reflect robust adoption of Zendesk Suite and Zendesk Sunshine solutions.
What's in the Offing for Jack Henry's (JKHY) Q2 Earnings?
by Zacks Equity Research
Jack Henry's (JKHY) fiscal second-quarter results are expected to reflect portfolio strength across all the segments.
Factors Setting the Tone for Seagate's (STX) Q2 Earnings
by Zacks Equity Research
Seagate's (STX) second-quarter fiscal 2020 results are likely to reflect strength in enterprise HDD sales amid stiff competition from Western Digital.
Microchip (MCHP) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Microchip (MCHP) third-quarter fiscal 2020 earnings are likely to reflect solid demand witnessed by latest microcontrollers amid trade war woes and Huawei ban.
Factors Setting the Tone for Lumentum's (LITE) Q2 Earnings
by Zacks Equity Research
Lumentum Holdings (LITE) second-quarter fiscal 2020 results are likely to reflect strength in Commercial Lasers amid weakness in 3D sensing demand.
Zynga (ZNGA) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Zynga's (ZNGA) fourth-quarter 2019 results are likely to benefit from growth in its mobile live services supported by new and existing franchise games.